Company news

KORU Medical Systems, Inc. news in 2026

KORU Medical Systems, Inc.'s news releases, calls and decks from 2026, newest first.

View company

KORU Medical Systems to Participate in Upcoming Investor Conferences

November 4, 2026

KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026

October 20, 2026

KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance: : KORU Medical Systems (KRMD)

August 5, 2026

KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference

July 29, 2026

KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026: : KORU Medical Systems (KRMD)

July 15, 2026

KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026

July 15, 2026

KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress

May 18, 2026

KORU Medical Systems Announces First Quarter 2026 Results

May 6, 2026

KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026

April 16, 2026

KORU Medical Systems Announces EU MDR Certification for the Freedom60 Infusion Pump with Prefilled Syringe Compatibility

March 16, 2026

KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility

March 12, 2026

KORU Medical Systems Announces CEO Transition

March 12, 2026

KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance

March 12, 2026

KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

February 26, 2026

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO, Expanding Label for FreedomEDGE Infusion System

January 30, 2026

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

January 29, 2026

KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow

January 12, 2026

KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 5, 2026

Calls in 2026

Decks in 2026